wr 1065 has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeRemer, SJ; Dou, C; Ensminger, WD; Levi, M; Smith, DE | 1 |
| Ensminger, WD; Lawrence, TS; Levi, M; Smith, DE; Symon, Z | 1 |
2 other study(ies) available for wr 1065 and Experimental Hepatoma
| Article | Year |
|---|---|
Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.
Topics: Amifostine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Disease Models, Animal; Drug Delivery Systems; Drug Screening Assays, Antitumor; Femoral Vein; Infusions, Intravenous; Liver Neoplasms, Experimental; Male; Mercaptoethylamines; Neoplasm Transplantation; Portal Vein; Prodrugs; Rats; Rats, Sprague-Dawley | 2004 |
Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model.
Topics: Amifostine; Analysis of Variance; Animals; Hepatocytes; Infusions, Intravenous; Liver Neoplasms, Experimental; Male; Mercaptoethylamines; Micronucleus Tests; Portal Vein; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley | 2001 |